Herbalife's Quiet Regime Change: The Club Replaces the App

A new interim CEO and CFO are rebuilding the growth story around 64,000 Nutrition Clubs and India, while Pro2col — the centerpiece of 2025's pitch — is demoted to a beta side project.

HLF · Earnings Call · 2026-11-02

The beat is not the story

Herbalife's third quarter looked like another modest operating beat. Net sales came in at $1.4 billion, up 6% reported and 7.6% in constant currency, the fifth consecutive quarter of growth. Adjusted EBITDA was $182 million, above guidance, and the adjusted EBITDA margin expanded 70 basis points to 13.5%. Net income was $59 million, or $0.64 adjusted EPS. Management also achieved its 2.0x net leverage target and authorized a $250 million share repurchase. The stock has participated only modestly: shares are up about 6% over the last 90 days, but remain roughly 78% below the 2019 peak. The real news is not the quarter. It is the regime change underneath it. John DeSimone, previously CFO, is now interim CEO. Scott Schaefer is the new CFO. And the strategic center of gravity has moved. For the past several quarters, the pitch was Pro2col, personalized nutrition, hyper-customized supplements, and a digital platform that would capture consumer transactions. In this call, Nutrition Clubs are the first strategic priority, Bioniq is the growth brand, and Pro2col is mentioned mainly when an analyst asks about it. That is a meaningful shift in what management wants investors to underwrite.

Pro2col moves from centerpiece to parallel path

The prior calls were explicit. In August 2025, then-CEO Stephan Gratziani described the Pro2col beta with enthusiasm: “we actually have around just over 7,000 distributors that opted in, which, quite honestly, it was beyond the expectations that we had” — Stephan Paulo Gratziani, Chief Executive Officer · 2025-08-06. John DeSimone, then CFO, added that guidance included the cost of Pro2col but not the revenue, because the commercial launch was still ahead. On the April 2025 call he said: “We have not included revenue yet because when we launch the app in beta, it will be July.” — John DeSimone, Chief Financial Officer · 2025-04-30 The implication was that Pro2col would become a real monetization layer. This quarter, the language is defensive. Asked directly about Pro2col, DeSimone reframed it as one piece of a broader platform:

Pro2col was never our entire customer engagement platform. It was meant to be just one element of it. And it was designed at least currently for one particular approach to operating. It's still in beta. Its usage is low. We're going to continue taking a parallel path with Pro2col, but we're also developing a more broader customer engagement app/platform...
John DeSimone, Interim Chief Executive Officer · 2026-11-02

That is not a cancellation, but it is a demotion. The new platform is modular, configurable, and starts with the "24 games" in the first quarter of 2027, followed by challenges and customer engagement modules. Management now targets capturing at least 50% of distributors' global consumer transactions inside its technology ecosystem over three years — a concrete KPI, but a long-dated one. The old story required Pro2col to become the platform. The new story requires the platform to support the club. That is a lower-risk, lower-optionality framing.

The club is the strategy now

DeSimone's prepared remarks kept returning to a simple principle: “Herbalife succeeds when our distributors succeed.” — John DeSimone, Interim Chief Executive Officer · 2026-11-02 The operating expression of that is the Nutrition Club. Herbalife has over 64,000 clubs globally, almost 9,000 in the U.S., and those U.S. clubs accounted for 42% of U.S. volume in the third quarter. Club productivity rose more than 10% year over year in each quarter of 2026, and customer traffic through clubs rose more than 7% this quarter. Management is creating a dedicated internal Nutrition Club organization with tailored products, training, and programs — the first of what it says will be more vertical organizations around major distributor business models. This is a more grounded story than the personalized-nutrition narrative. It is also more defensible. A club is a physical community with recurring traffic; an app is a feature that can be copied. The company is pairing that with Bioniq brand expansion: more personalized nutrition SKUs, sports performance, healthy lifespan, and a separate business opportunity. Life I/O is being folded into Bioniq because, as DeSimone put it, "you don't need two brands." The company also continues to position its existing products for consumers using GLP 1 medications, arguing that protein, teas, and targeted nutrition can coexist with the drug class rather than compete with it. But the Bioniq hype is still ahead of the numbers. DeSimone was candid: “the energy and excitement around the Bioniq brand is much greater than the actual sales” — John DeSimone, Interim Chief Executive Officer · 2026-11-02. He disclosed fewer than 50,000 units sold since launch. That is tiny for a $1.4 billion-revenue company. Bioniq may become meaningful, but it is not yet a needle-mover.

India carries the quarter; margins get more gradual

The geographic mix explains both the beat and the caution. India net sales rose $87 million, or 39% reported and 52% in local currency, on nearly 50% volume growth. Asia Pacific constant-currency net sales rose 26%; Latin America grew 5.1% in constant currency; North America grew 1.7%. EMEA and China offset the strength. The India GST change is now being lapped in the fourth quarter, so the growth rate should moderate. Management raised full-year net sales guidance but kept full-year adjusted EBITDA at $670 million to $690 million reported, while Q4 adjusted EBITDA guidance of $145 million to $165 million implies a step down from Q3. The margin language is the tell. Schaefer said: “We expanded adjusted EBITDA margin by 70 basis points this quarter. Looking ahead, we expect the path to further expansion to be more gradual.” — Scott Schaefer, Chief Financial Officer · 2026-11-02 He promised three-year margin objectives on the next call. The last filed quarter showed $1.3 billion of total revenue, up 5% year over year, with a gross margin of 77.7%. The Q3 release improved the top line to $1.4 billion, but the margin trajectory is no longer a straight line. The balance sheet is better, but still levered. Effective net cash was negative $1.6 billion in the latest filing, and interest coverage was 3.2x. The 2.0x net leverage ratio is real progress against the long-term target of $1.4 billion total debt and $1 billion net debt. The new $250 million buyback is a reversal from prior messaging. In November 2025, DeSimone said plainly: “buybacks are not a priority right now” — John DeSimone, Chief Financial Officer · 2025-11-05. Now they are. That is a capital-allocation signal: management believes the debt paydown path is sufficiently de-risked to return cash while still investing in clubs, Bioniq, and the platform.

What to watch

The fourth quarter will test whether the India lap is manageable, whether EMEA and China stabilize, and whether the new tone on Pro2col becomes a full write-down in investor minds. The more important leading indicator is whether the Nutrition Club vertical produces measurable productivity gains beyond the U.S. and whether Bioniq can move from excitement to units. The company has bought itself time with five quarters of growth and a cleaner balance sheet. But it has also swapped a high-optionality digital story for a blocking-and-tackling club story. That is probably the right trade for the next twelve months. It is not the same story investors were sold last year.